Hastings David C

Trevi Therapeutics, Inc. · Chief Financial Officer

Hastings David C is listed in public filings as officer: Chief Financial Officer. This Hastings David C insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Trevi Therapeutics, Inc. (TRVI), SCYNEXIS, Inc. (SCYX), and Arbutus Biopharma Corporation (ABUS). Investors use Hastings David C's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Arbutus Biopharma CorporationABUS$73k22.2k sharesSellFeb 4, 2025$3.28--